Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Clinical Trial
Phase of Trial: Phase IV
Latest Information Update: 06 Dec 2019
Price : $35 *
At a glance
- Drugs Semaglutide (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 18 Oct 2019 Planned number of patients changed from 2250 to 1387.
- 26 Apr 2019 Planned End Date changed from 19 Nov 2021 to 21 Oct 2022.
- 23 Aug 2018 Planned End Date changed from 31 Dec 2021 to 19 Nov 2021.